Evolut R in bicuspid valve anatomies

Similar documents
Andrzej Ochala, MD Medical University of Silesia, Katowice, Poland

TAVI IN BICUSPID AOV AND VALVE-IN-VALVE

Is TAVI ready for prime time in: - Intermediate risk patients? - Low risk patients?

Transcatheter Aortic Valve Implantation Management of risks and complications

Optimal Imaging Technique Prior to TAVI -Echocardiography-

TAVI Technology and Procedural Changes

Image Assistance in TAVI Why CT? Won-Jang Kim, MD, PhD Clinical Assistant Professor of Medicine, Heart Institute, Asan Medical Center, Seoul, Korea

TAVR or SAVR: Beyond the STS Score

TAVI Implantation: Rapid Pacing, Pre and Post Dilatation

Joseph E. Bavaria, M.D. Roberts Measy Professor and Vice Chief CardioVascular Surgery Director: Thoracic Aortic Surgery Program University of

Corrado Tamburino, MD, PhD

Prof. Dr. Thomas Walther. TAVI in ascending aorta / aortic root dilatation

The Role of Imaging in Transcatheter Aortic Valve Implantation

Transcatheter aortic valve implantation for severe aortic valve stenosis with the ACURATE neo2 valve system: 30-day safety and performance outcomes

CoreValve Evolut R Technology review and Clinical Results. Paul TL Chiam

Severity of AS Degree of AV calcification (? Bicuspid AV), annulus size, & aortic root

SAPIEN 3 Sizing Considerations:

Imaging in TAVI. Jeroen J Bax Dept of Cardiology Leiden Univ Medical Center The Netherlands Davos, feb 2013

Comments restricted to Sapien and Corevalve 9/12/2016. Disclosures: Core Lab contracts with Edwards Lifesciences, Middlepeak, Medtronic

PVL Assessment. Is paravalvular regurgitation after TAVR still an important consideration in 2018?

Joseph E. Bavaria, M.D. Roberts Measy Professor and Vice Chief CardioVascular Surgery Director: Thoracic Aortic Surgery Program University of

Transcatheter Aortic Valve Replacement with Evolut-R

Transcatheter valve-in-valve implantation for degenerated surgical bioprostheses

An Update on the Edwards TAVR Results. Zvonimir Krajcer, MD Director, Peripheral Intervention Texas Heart Institute at St.

Current Evidence in TAVI patients using ACURATE and LOTUS valves

TAVR for low-risk patients in 2017: not so fast.

History. 2D echo before TAVI. 88 female Hypertensive - hyperlipidemic History of LOC syncope Echo: severe AS AV gradient 90 mmhg Good LV LVH

Dr.ssa Loredana Iannetta. Centro Cardiologico Monzino

Echo Assessment Pre-TAVI

Outcome of Next-Generation Transcatheter Valves in Small Aortic Annuli: A Multicenter Propensity-Matched Comparison

ΔΙΑΔΕΡΜΙΚΗ ΑΝΣΙΚΑΣΑΣΑΗ ΑΟΡΣΙΚΗ ΒΑΛΒΙΔΑ αντιμετώπιση επιπλοκών ΠΕΣΡΟ. ΔΑΡΔΑ, MD, FESC IICE 2012

PARAVALVULAR LEAK POST TAVR. Elements of Follow-up Post TAVR

Mitral Programme Update

CoreValve in a Degenerative Surgical Valve

Transcatheter Aortic Valve Implantation Present Status and Perspectives

Transcatheter aortic valves in aortic regurgitation Gry Dahle Dept of Cardiothoracic- and vascular surgery Rikshospitalet, Oslo University Hospital,

Percutaneous Therapy for Calcific Mitral Valve Disease

Progress In Transcatheter Aortic Valve Implantation

Dr Winnie Sze-Wun Chan. Cardiac Team Deputy Team Head Department of Radiology and Imaging Queen Elizabeth Hospital Hong Kong

*Core lab for numerous trials, for which I receive no direct compensation from sponsors.

TAVI EN INSUFICIENCIA AORTICA

TAVI: Present and Future Perspective

Transcatheter Aortic Valve Implantation. SSVQ November 23, 2012 Centre Mont-Royal 15:40

2/28/2010. Speakers s name: Paul Chiam. I have the following potential conflicts of interest to report: NONE. Antegrade transvenous transseptal route

30-Day Outcomes Following Implantation of a Repositionable Self-Expanding Aortic Bioprosthesis: First Report From the FORWARD Study

Federico M Asch MD, FASE MedStar Heart and Vascular Institute Georgetown University Washington, DC

How Do I Evaluate a Patient Being Considered for TAVR? Sunday, February 14, :00 11:25 PM 25 min

Incidence and Management of Early Implant Failure after Transcatheter Aortic Valve Implantation

Emerging Transcatheter Aortic Valve Technologies

New Cardiovascular Devices and Interventions: Non-Contrast MRI for TAVR Abhishek Chaturvedi Assistant Professor. Cardiothoracic Radiology

TAVI: The Real Deal? Marc Pelletier, MD Head, Department of Cardiac Surgery New Brunswick Heart Centre

Valve Replacement without a Scalpel Transcatheter Aortic Valve Replacement (TAVR) Charles T. Klodell, M.D.

7 th Conference of Transcatheter Heart Valve Therapies

TAVI in Korea, How to Avoid Conduction

Pre-procedural CT angiography for Transcatheter Aortic Valve Implantation: What a Radiologist Needs to Know?

TAVR-Update Andrzej Boguszewski MD, FACC, FSCAI Vice Chairman, Cardiology Mid-Michigan Health Associate Professor Michigan State University, Central

Pacemaker rates Second generation TAVI Devices

A Thoughtful Synthesis of the TAVR Landscape: What s New, What s Needed and is There a Best-in-Class?

Aortic valve calcium load before TAVI: Is it important?

transcatheter heart valve: THV TAVI transcatheter aortic valve implantation

TAVI Versus Suturless Valve In Intermediate Risk Patients

Aortic Stenosis. TAVR available devices Ioannis Iakovou, MD, PhD

Portico (St. Jude Medical Inc, St.

TAVR: Current Valve Types. Patient Selection

Annular Stabilization Techniques in the Context of Aortic Valve Repair

New imaging modalities for assessment of TAVI procedure and results. R Dulgheru, MD Heart Valve Clinic CHU, Liege

Over the past 10 years, transcatheter aortic valve

TAVR: Echo Measurements Pre, Post And Intra Procedure

Hemodynamics Benefit of Supra-Annular Design in Failed Bio-Prosthetic Valves

Aortic Stenosis. TAVR available devices Ioannis Iakovou, MD, PhD

How to Adapt the Implantation Technique for the New SAPIEN 3 Transcatheter Heart Valve Design

Technical consideration of aquiring and analyzing 3D TEE volume data sets (EchoPac ) Phasic changes of the aortic root throughout the cardiac cycle

Vascular complications of embolized core valve

TAVR Cases. Disclosures 2/17/2018. February 17, :15 3:30 PM 15 min

Update on Percutaneous Therapies for Structural Heart Disease. William Thomas MD Director of Structural Heart Program Tucson Medical Center

Heart Team For TAVI Who and How?

Critical role of multi-modality planning in Transcatheter Mitral Valve Replacement

The Lotus Valve, The Latest Developments and Future Aspects. Professor Jan Harnek MD PhD FESC Lund University Sweden

TAVR SPRING 2017 The evolution of TAVR

Management of Difficult Aortic Root, Old and New solutions

Transcatheter Aortic Valve Replacement

Percutaneous Management of Severe AS in Octagenarians. Phillip Matsis FRACP FCSANZ Interventional Cardiologist Wakefield Heart Centre Wellington

TAVI: FUTURE DEVELOPMENTS

Transoesophageal echocardiography and decision making in valve surgery

Stainless Steel. Cobalt-chromium

LIFE IS DIFFERENT WITH PRO. Evolut PRO System

Transcatheter aortic valve implantation and pre-procedural risk assesment

TAVI: Transapical Procedures

Procedural Guidance of TAVR: How to Assure it Goes Right and What to Do If It Doesn t

Clinical outcomes and prognostic factors of transcatheter aortic valve implantation in bicuspid aortic valve patients

Aortic valve implantation using the femoral and apical access: a single center experience.

Ian T. Meredith AM. MBBS, PhD, FRACP, FCSANZ, FACC, FAPSIC. Monash HEART, Monash Health & Monash University Melbourne, Australia

Potential conflicts of interest

Lessons From The Computer Model and How We Do Root Replacement

Edwards Transcatheter AVR: Have the Outcomes Changed after CE Approval?

Aortic valve repair: When and how to employ this novel approach?

The Future of Medicine. Who to TAVR? Azeem Latib MD EMO-GVM Centro Cuore Columbus and San Raffaele Scientific Institute, Milan, Italy

Imaging to select patients for Transcatheter TV

I will not discuss off label use or investigational use in my presentation.

New York Valves Patient focused evidence-based approach. New York City: 6 December Antonio Colombo

Transcription:

Evolut R in bicuspid valve anatomies U. Gerckens MD University of Rostock, Germany

Potential conflicts of interest Speaker's name: Ulrich Gerckens I have the following potential conflicts of interest to report: Proctor: Boston Scientific, Medtronic Receipt of honoraria or consultation fees: Boston Scientific, Medtronic

BAV morphology & Classification Type 0: 26.7% Type 1: 68.3% Type 2: 5.0% Sievers et al. J Thorac Cardiovasc Surg 2007 Mylotte D., JACC. 2014;64(22):2330-2339

BAV Classification in TAVI Era Jilaihawi et al. JACC imag. 2016;9:1145 58 Jilaihawi et al. JACC imag. 2016

- Frame expansion at different levels Bicuspid valves CT Scan, post implantation Annular level Supra annular level

Challenges in bicuspid valves Often heavily calcified Incomplete valve expansion ( calcified raphe ) Paravalvular leak Annulus rupture Angulated aortic root Frequently associated with ascending aortic aneurysm Risk of rupture/dissection Oval shaped valve area and eccentric annulus Risk of paravalvular leak Long-term durability of the TAVI valve?

Sizing in bicuspid What to consider for sizing: Virtual basal ring or EOA or Intercommissural distance? Annular sizing or supraannular CT based measurement or balloon sizing to identify effective orifice area ( EOA), - best oversizing range?

How Sizing in bicuspid Annulus Measurement with Valve Leaflets analysis Bicuspid Type 1 ( Raphé RCS / LCS) EOA or Functional diameter Analysis of Leaflets Anatomy (Bicuspid, Ca++) should be added to annulus measurement to optimize valve size choice and define optimal valve position before TAVI Functional Annulus Diameter

Key discussion points Not just Downsizing ---- but how to measure for optimal / best sizing! Should we use annular or supra-annular sizing? If supra-annular, which level above basal plane? Anchoring zone? Role/impact of Intercommissural distance and of the calcified Raphe ( > 4mm)? Balloon sizing for identify the effective orifice area (EOA) and anchoring level? Risk of under sizing Risk of over sizing o Pop-out o PVL o Valve embolization 9 CoreValve Evolut R 34 mm In-service Medtronic - Confidential o Annular rupture o Pacemaker rate o Valve dislodgement o Excess frame/leaflet strain

Case example self-expanding prosthesis in bicuspid anatomy

Bicuspid valve clinical example sizing/implantation technique MSCT sizing (core lab) Perimeter = 81,2 / 25,8mm derived Sizing chart 29mm Evolute R Trondheim, J. I. G. 18/2/2016

Bicuspid valve clinical example sizing/implantation technique TEE valve anatomy Trondheim, J. I. G. 18/2/2016

Bicuspid valve clinical example sizing/implantation technique TEE valve anatomy Trondheim, Dr. Bjørnar Grenne, J. I. G. 18/2/2016

Bicuspid valve clinical example sizing/implantation technique Angio pre Trondheim, J. I. G. 18/2/2016

Bicuspid valve clinical example sizing/implantation technique Angio balloon sizing 22mm TRUE Trondheim, J. I. G. 18/2/2016

Bicuspid valve clinical example sizing/implantation technique TEE balloon sizing 22mm TRUE Trondheim, J. I. G. 18/2/2016

Bicuspid valve clinical example sizing/implantation technique Angio 26mm Evolut R implantation Trondheim, J. I. G. 18/2/2016

Bicuspid valve clinical example sizing/implantation technique TEE: 26mm Evolut R Trondheim, J. I. G. 18/2/2016

Bicuspid valve clinical example sizing/implantation technique 26mm Evolut R post dilatation same 22mm balloon Trondheim, J. I. G. 18/2/2016

Bicuspid valve clinical example sizing/implantation technique TEE: 26mm Evolut R: postdil. 22mm TRUE Trondheim, J. I. G. 18/2/2016

Bicuspid valve clinical example sizing/implantation technique Angio 26mm Evolut R final result Trondheim, J. I. G. 18/2/2016

Bicuspid valve clinical example sizing/implantation technique TEE: 26mm Evolut R final result Trondheim, J. I. G. 18/2/2016

Final Peak-to-peak: 4 mmhg Pmean: 12,7 mmhg

Evolut R in bicuspid valve anatomies Bicuspid aortic valve for TAVI requires valve frame implantation accordingly to leaflet level to ensure suprannular functioning of the self expandable THV Possibility of resheathing, repositioning and supraanular functioning are relevant advantages Self expanding nitinol valvular frame can expand even in the post implant period to conform to the anatomy THV in BAV required often post-dilatation (no balloon upsizing) for optimal THV expansion (TEE or multiplanar view is helpful)

Take home message Identify a bicuspid valve morphology and criterias! Sizing concept in bicuspid still under evaluation (value of balloon sizing, CT based supra-annular sizing, intercommissural distance, raphe length) Not only Downsizing best and correct sizing (EOA) needed Implant depth in relation to the anchoring zone (different from annular plane to maintain suprannular functioning! Balloon sizing can be useful for identify the effective orifice area (EOA),for sizing and to identify the anchoring level